Nevro [NVRO] vs Zimvie [ZIMV] Detailed Stock Comparison

Nevro Corp.

NYSE
Loading...

Zimvie Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Nevro Corp. wins in 5 metrics, Zimvie Inc. wins in 13 metrics, with 0 ties. Zimvie Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Nevro Corp. Zimvie Inc. Better
P/E Ratio (TTM) 144.40 -20.20 Nevro Corp.
Price-to-Book Ratio 0.96 1.30 Nevro Corp.
Debt-to-Equity Ratio 108.86 56.82 Zimvie Inc.
PEG Ratio -2.26 3.03 Zimvie Inc.
EV/EBITDA -2.15 17.09 Zimvie Inc.
Profit Margin (TTM) -27.77% -4.39% Zimvie Inc.
Operating Margin (TTM) -21.79% 3.33% Zimvie Inc.
EBITDA Margin (TTM) N/A 3.33% N/A
Return on Equity -43.29% -4.76% Zimvie Inc.
Return on Assets (TTM) -9.95% 0.51% Zimvie Inc.
Free Cash Flow (TTM) $-29.23M $7.49M Zimvie Inc.
1-Year Return -56.06% 36.91% Zimvie Inc.
Price-to-Sales Ratio (TTM) 0.55 1.21 Nevro Corp.
Enterprise Value $180.16M $699.90M Zimvie Inc.
EV/Revenue Ratio 0.44 1.58 Nevro Corp.
Gross Profit Margin (TTM) 62.45% 64.55% Zimvie Inc.
Revenue per Share (TTM) $11 $16 Zimvie Inc.
Earnings per Share (Diluted) $-3.06 $-0.69 Zimvie Inc.
Beta (Stock Volatility) 0.82 2.06 Nevro Corp.
Short % of Float N/A 1.93% N/A

Nevro Corp. vs Zimvie Inc. Stock Performance Analysis

Loading Price Chart...

NVRO
ZIMV

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nevro Corp.0.00%N/AN/AN/AN/AN/A
Zimvie Inc.0.00%0.05%0.58%1.23%112.89%103.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nevro Corp.-56.06%-92.38%-94.65%-89.12%-76.92%-76.92%
Zimvie Inc.36.91%131.59%-57.04%-57.04%-57.04%-57.04%

Performance & Financial Health Analysis: Nevro Corp. vs Zimvie Inc.

MetricNVROZIMV
Market Information
Market Cap i$224.09M$535.72M
Market Cap CategoryMicro capN/A
10 Day Avg. Volume i1,058,636256,326
90 Day Avg. Volume i1,147,389302,282
Last Close$5.84$18.99
52 Week Range$3.16 - $13.84$8.15 - $19.01
% from 52W High-57.80%-0.11%
All-Time High$188.14 (Dec 21, 2020)$50.40 (Feb 14, 2022)
% from All-Time High-96.90%-62.32%
Growth Metrics
Quarterly Revenue Growth-0.09%0.00%
Quarterly Earnings Growth-0.09%0.00%
Financial Health
Profit Margin (TTM) i-0.28%-0.04%
Operating Margin (TTM) i-0.22%0.03%
Return on Equity (TTM) i-0.43%-0.05%
Debt to Equity (MRQ) i108.8656.82
Cash & Liquidity
Book Value per Share (MRQ)$6.11$14.64
Cash per Share (MRQ)$7.72$2.49
Operating Cash Flow (TTM) i$-19,439,000$11.97M
Levered Free Cash Flow (TTM) i$-4,766,875$11.75M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Nevro Corp. vs Zimvie Inc.

MetricNVRO (May 17, 2025)ZIMV (Nov 10, 2025)
Price Ratios
P/E Ratio (TTM) i144.40-20.20
Forward P/E i-2.2628.77
PEG Ratio i-2.263.03
Price to Sales (TTM) i0.551.21
Price to Book (MRQ) i0.961.30
Market Capitalization
Market Capitalization i$224.09M$535.72M
Enterprise Value i$180.16M$699.90M
Enterprise Value Metrics
Enterprise to Revenue i0.441.58
Enterprise to EBITDA i-2.1517.09
Risk & Other Metrics
Beta i0.822.06
Book Value per Share (MRQ) i$6.11$14.64

Financial Statements Comparison: Nevro Corp. vs Zimvie Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNVRO (2024)ZIMV (2024)
Revenue/Sales i408.52M449.75M
Cost of Goods Sold i138.99M162.30M
COGS % of Revenue i34.0%36.1%
Gross Profit i269.53M287.45M
Gross Margin i66.0%63.9%
Research & Development i51.51M26.91M
Operating Income (EBIT) i-94.70M-2.10M
Operating Margin i-23.2%-0.5%
EBITDA i-67.70M48.17M
EBITDA Margin i-16.6%10.7%
Pre-Tax Income i-112.35M-23.59M
Pre-Tax Income % of Revenue i-27.5%-5.2%
Income Tax i1.09M10.24M
Income Tax % of Revenue i0.3%2.3%
Net Income (Profit) i-113.44M-25.83M
Profit Margin i-27.8%-5.7%

Balance Sheet & Liquidity Metrics

MetricNVRO (2024)ZIMV (2024)
Cash & Equivalents i94.54M74.97M
Total Current Assets i476.00M257.29M
Total Current Assets % of Revenue i116.5%57.2%
Total Current Liabilities i102.94M133.94M
Total Current Liabilities % of Revenue i25.2%29.8%
Long-Term Debt i213.19M228.67M
Long-Term Debt % of Revenue i52.2%50.8%
Total Shareholders Equity i231.01M381.71M
Retained Earnings i-812.85M-466.64M
Retained Earnings % of Revenue i-199.0%-103.8%
Property, Plant & Equipment i36.77M0

Cash Flow Statement Comparison

MetricNVRO (2024)ZIMV (2024)
Operating Cash Flow i-25.99M33.89M
Operating Cash Flow % of Revenue i-6.4%7.5%
Capital Expenditures i-9.79M-6.68M
Free Cash Flow i-29.23M7.49M
FCF Margin i-7.2%1.7%
Debt Repayment i0-290.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNVROZIMV
Shares Short iN/A531,525
Short Ratio iN/A0.81
Short % of Float iN/A1.93%
Shares Outstanding i37.82M28.20M
Float Shares i34.23M21.66M
% Held by Insiders i2.84%2.73%
% Held by Institutions i110.59%90.96%
% Held by Public i-13.43%6.31%

Dividend Analysis & Yield Comparison: Nevro Corp. vs Zimvie Inc.

MetricNVROZIMV
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A